Stock Based Compensation - Omnibus Incentive Plan (Details) - Omnibus Plan - Stock Options - $ / shares		6 Months Ended		12 Months Ended
	May 27, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Stock based compensation
Number of additional shares authorized	1,000,000
Number of shares available for grant	2,200,000	920,657
Stock options granted (in shares)		30,452	0
Number of shares
Balance at beginning of year (in shares)		778,835
Granted (in shares)		30,452	0
Exercised (in shares)		(14,075)
Expired (in shares)		(1,320)
Forfeited (in shares)		(6,460)
Balance at end of year (in shares)		787,432		778,835
Options: Options vested and exercisable		636,083
Options: Options vested and expected to vest		787,432
Weighted-Average Exercise Price
Balance at beginning of year (in dollars per share)		$ 18.02
Granted (in dollars per share)		14.42
Exercised (in dollars per share)		4.04
Expired (in dollars per share)		21.75
Forfeited (in dollars per share)		29.62
Balance at end of year (in dollars per share)		18.03		$ 18.02
Weighted-Average Exercise Price: Options vested and exercisable		16.00
Weighted-Average Exercise Price: Options vested and expected to vest		$ 18.03
Weighted- Average Remaining Contractual Term (in Years)
Balance (in years)		5 years 1 month 24 days		5 years 7 months 2 days
Granted (in years)		6 years 9 months 18 days
Weighted-Average Remaining Contractual Term (in Years): Options vested and exercisable		4 years 10 months 9 days
Weighted-Average Remaining Contractual Term (in Years): Options vested and expected to vest		5 years 1 month 24 days
Number of unvested options scheduled to vest
Non-Vested Options as of beginning of period		127,357
Granted (in shares)		30,452	0
Forfeited (in shares)		(6,460)
Non-Vested Options as of end of period		151,349		127,357
Weighted-Average Grant Date Fair Value
Non-Vested, beginning balance		$ 17.42
Granted: Weighted-Average Grant Date Fair Value		8.62
Forfeited: Weighted-Average Grant Date Fair Value		17.43
Non-Vested, ending balance		$ 15.65		$ 17.42
Valuation Assumptions:
Expected term in years		4 years 3 months
Volatility (as a percent)		77.50%
Risk-free interest rate		2.44%
Dividend yield (as a percent)		0.00%
Granted: Weighted-Average Grant Date Fair Value		$ 8.62
2022
Number of unvested options scheduled to vest
Non-Vested Options as of end of period		151,349
Valuation Assumptions:
Term of award		P7Y
Vesting period		2 years